Teva Pharmaceuticals has launched a new digital support platform aimed at reshaping how people living with schizophrenia—and their care partners—access community-driven resources.
Called the Home Ground Schizophrenia Community, the online platform is designed to go beyond clinical treatment, offering practical tools, lived-experience insights, and peer-informed support intended to reduce isolation and improve day-to-day coping.
Developed in collaboration with people living with schizophrenia and care partners, Teva says the platform was built to “connect the community, help people learn from others, feel less alone and address real-life needs with resources that are useful, understandable and actionable.”
The launch comes against the backdrop of schizophrenia’s profound global impact. The condition affects roughly 1% of the world’s population, and research cited by the company suggests that more than 75% of people with psychotic disorders experience loneliness—a factor linked to worsening depression, cognitive decline, and poorer physical health.
For advocates involved in the initiative, the goal is to close that gap between treatment and lived experience.
“Schizophrenia care doesn’t end with diagnosis and a prescription. The day-to-day realities, including isolation, can be very challenging and addressing these barriers is important for the recovery journey,” said Dan Laitman, a Home Ground Ambassador and community advocate living with schizophrenia.
“As someone who has firsthand experience with the power of holistic care, I see Home Ground Schizophrenia Community as an essential resource that brings peer perspectives and practical support together in one place, giving individuals and care partners a true home for support alongside their clinical care.”
Teva says social isolation remains one of the biggest barriers to recovery, and the platform is intended to address that head-on by embedding social connection into everyday care planning.
“For those living with schizophrenia, it is clear that social isolation represents a fundamental and often primary impediment to achieving and maintaining successful recovery,” said Heather DeMyers, Vice President of Marketing, US Innovative Medicines at Teva.
“Home Ground Schizophrenia Community was developed to address this head-on. By offering practical community resources and easy-to-use tools, the platform aims to integrate social support into treatment plans so no one has to face these challenges alone.”
The Home Ground platform includes symptom tracking tools to monitor mood, sleep, stress, and triggers; emotional wellness resources and peer videos; independent living guides focused on routines and goal-setting; physical health checklists; and listings for in-person and virtual community events.
Care partners are also central to the initiative, with the platform offering resources aimed at reducing stigma and improving daily support.
“As a care partner, I’ve experienced firsthand just how isolating schizophrenia can be, and many people I’ve spoken with feel misunderstood and helpless as a result,” said Nicole Drapeau Gillen, care partner, schizophrenia advocate and Home Ground Ambassador.
“By listening to stories from the community and providing practical tools to manage our daily lives, Home Ground helps dismantle stigma and empowers us to take manageable steps, stay connected and play an active role in care.”
_256_275.jpg)
